The role of gap junctional intercellular communication during inflammatory processes is not well understood. In particular, changes in the expression and function of vascular endothelial connexins (gap junction proteins) in response to inflammatory agents has not been fully investigated. In this study, we used intercellular dye transfer methods to assess interendothelial communication in aortic segments isolated from mice treated with or without intraperitoneal lipopolysaccharide (LPS), a potent inflammatory mediator. LPS treatment resulted in a 49% decrease in endothelial dye coupling 18 h after injection. Western blots indicated that LPS treatment also caused a reduction in endothelial connexin40 (Cx40) levels to 33% of control levels. Connexin37 (Cx37) levels decreased only slightly after LPS treatment to 79% of control levels. We also examined endothelial communication in aortic segments isolated from Cx37–/– and Cx40–/– mice. LPS treatment caused a significantly greater decrease in dye transfer in endothelium isolated from Cx37–/– animals compared with endothelium from Cx40–/– animals (71 vs. 26% decrease). LPS injection caused a reduction in Cx40 levels in Cx37–/– endothelium, whereas LPS actually increased Cx37 levels in Cx40–/– endothelium. These results suggest that LPS mediates changes in endothelial gap junction-mediated communication, at least in part, through modulation of Cx40 and Cx37 levels.

Keywords:
Aorta, Endothelium, Intercellular communication, Connexin37, Connexin40, Gap junction, Lipopolysaccharide, Endotoxin, Sepsis
1.
Segal SS, Duling BR: Conduction of vasomotor responses in arterioles: A role for cell-to-cell coupling? Am J Physiol 1989;256:H838–H845.
2.
de Wit C, Roos F, Bolz SS, Kirchhoff S, Kruger O, Willecke K, Pohl U: Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res 2000;86:649–655.
3.
Figueroa XF, Paul DL, Simon AM, Goodenough DA, Day KH, Damon DN, Duling BR: Central role of connexin40 in the propagation of electrically activated vasodilation in mouse cremasteric arterioles in vivo. Circ Res 2003;92:793–800.
4.
Chaytor AT, Evans WH, Griffith TM: Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries. J Physiol 1998;508:561–573.
5.
Harris AL: Emerging issues of connexin channels: Biophysics fills the gap. Q Rev Biophys 2001;34:325–472.
6.
Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, Deutsch U, Sohl G: Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002;383:725–737.
7.
Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC: Plasma membrane channels formed by connexins: Their regulation and functions. Physiol Rev 2003;83:1359–1400.
8.
Bruzzone R, Haefliger JA, Gimlich RL, Paul DL: Connexin40, a component of gap junctions in vascular endothelium, is restricted in its ability to interact with other connexins. Mol Biol Cell 1993;4:7–20.
9.
Gabriels JE, Paul DL: Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res 1998;83:636–643.
10.
Larson DM, Haudenschild CC, Beyer EC: Gap junction messenger RNA expression by vascular wall cells. Circ Res 1990;66:1074–1080.
11.
Little TL, Beyer EC, Duling BR: Connexin 43 and connexin 40 gap junctional proteins are present in arteriolar smooth muscle and endothelium in vivo. Am J Physiol 1995;268:H729–H739.
12.
Reed KE, Westphale EM, Larson DM, Wang H-Z, Veenstra RD, Beyer EC: Molecular cloning and functional expression of human connexin37, an endothelial cell gap junction protein. J Clin Invest 1993;91:997–1004.
13.
Traub O, Hertlein B, Kasper M, Eckert R, Krisciukaitis A, Hulser D, Willecke K: Characterization of the gap junction protein connexin37 in murine endothelium, respiratory epithelium, and after transfection in human HeLa cells. Eur J Cell Biol 1998;77:313–322.
14.
van Kempen MJ, Jongsma HJ: Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol 1999;112:479–486.
15.
Yeh HI, Rothery S, Dupont E, Coppen SR, Severs NJ: Individual gap junction plaques contain multiple connexins in arterial endothelium. Circ Res 1998;83:1248–1263.
16.
Krüger O, Beny JL, Chabaud F, Traub O, Theis M, Brix K, Kirchhoff S, Willecke K: Altered dye diffusion and upregulation of connexin37 in mouse aortic endothelium deficient in connexin40. J Vasc Res 2002;39:160–172.
17.
Simon AM, McWhorter AR: Decreased intercellular dye-transfer and downregulation of non-ablated connexins in aortic endothelium deficient in connexin37 or connexin40. J Cell Sci 2003;116:2223–2236.
18.
Alexander C, Rietschel ET: Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001;7:167–202.
19.
Henneke P, Golenbock DT: Innate immune recognition of lipopolysaccharide by endothelial cells. Crit Care Med 2002;30:S207–S213.
20.
Raetz CR, Whitfield C: Lipopolysaccharide endotoxins. Annu Rev Biochem 2002;71:635–700.
21.
Bannerman DD, Goldblum SE: Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 2003;284:L899–L914.
22.
Levi M, ten Cate H, van der Poll T, van Deventer SJ: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993;270:975–979.
23.
Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994;271:226–233.
24.
Bannerman DD, Goldblum SE: Direct effects of endotoxin on the endothelium: Barrier function and injury. Lab Invest 1999;79:1181–1199.
25.
Bannerman DD, Fitzpatrick MJ, Anderson DY, Bhattacharjee AK, Novitsky TJ, Hasday JD, Cross AS, Goldblum SE: Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction. Infect Immun 1998;66:1400–1407.
26.
Martin MA, Silverman HJ: Gram-negative sepsis and the adult respiratory distress syndrome. Clin Infect Dis 1992;14:1213–1228.
27.
Volk T, Kox WJ: Endothelium function in sepsis. Inflamm Res 2000;49:185–198.
28.
Hinshaw LB: Sepsis/septic shock: Participation of the microcirculation: An abbreviated review. Crit Care Med 1996;24:1072–1078.
29.
Lidington D, Tyml K, Ouellette Y: Lipopolysaccharide-induced reductions in cellular coupling correlate with tyrosine phosphorylation of connexin 43. J Cell Physiol 2002;193:373–379.
30.
Lidington D, Ouellette Y, Tyml K: Endotoxin increases intercellular resistance in microvascular endothelial cells by a tyrosine kinase pathway. J Cell Physiol 2000;185:117–125.
31.
Tyml K, Wang X, Lidington D, Ouellette Y: Lipopolysaccharide reduces intercellular coupling in vitro and arteriolar conducted response in vivo. Am J Physiol Heart Circ Physiol 2001;281:H1397–H1406.
32.
Lidington D, Ouellette Y, Li F, Tyml K: Conducted vasoconstriction is reduced in a mouse model of sepsis. J Vasc Res 2003;40:149–158.
33.
Hu VW, Xie HQ: Interleukin-1-alpha suppresses gap junction-mediated intercellular communication in human endothelial cells. Exp Cell Res 1994;213:218–223.
34.
Hu J, Cotgreave IA: Differential regulation of gap junctions by proinflammatory mediators in vitro. J Clin Invest 1997;99:2312–2316.
35.
van Rijen HVM, van Kempen MJA, Postma S, Jongsma HJ: Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine 1998;10:258–264.
36.
Simon AM, Goodenough DA, Li E, Paul DL: Female infertility in mice lacking connexin 37. Nature 1997;385:525–529.
37.
Simon AM, Goodenough DA, Paul DL: Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol 1998;8:295–298.
38.
Simon AM, McWhorter AR: Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 2002;251:206–220.
39.
Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP: Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem 1995;270:16395–16401.
40.
Loo LW, Berestecky JM, Kanemitsu MY, Lau AF: pp60src-mediated phosphorylation of connexin 43, a gap junction protein. J Biol Chem 1995;270:12751–12761.
41.
Hertzberg EL: A detergent-independent procedure for the isolation of gap junctions from rat liver. J Biol Chem 1984;259:9936–9943.
42.
Koval M, Geist ST, Westphale EM, Kemendy AE, Civitelli R, Beyer EC, Steinberg TH: Transfected connexin45 alters gap junction permeability in cells expressing endogenous connexin43. J Cell Biol 1995;130:987–995.
43.
Schubert AL, Schubert W, Spray DC, Lisanti MP: Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry 2002;41:5754–5764.
44.
Grisham MB, Everse J, Janssen HF: Endotoxemia and neutrophil activation in vivo. Am J Physiol 1988;254:H1017–H1022.
45.
Triantafilou M, Triantafilou K: Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002;23:301–304.
46.
Heine H, Lien E: Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 2003;130:180–192.
47.
Zhang G, Ghosh S: Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res 2000;6:453–457.
48.
Diks SH, van Deventer SJ, Peppelenbosch MP: Lipopolysaccharide recognition, internalisation, signalling and other cellular effects. J Endotoxin Res 2001;7:335–348.
49.
Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, Polentarutti N, Muzio M, Arditi M: Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 2000;275:11058–11063.
50.
Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999;274:10689–10692.
51.
Lidington D, Ouellette Y, Tyml K: Communication of agonist-induced electrical responses along ‘capillaries’ in vitro can be modulated by lipopolysaccharide, but not nitric oxide. J Vasc Res 2002;39:405–413.
52.
Gingalewski C, Wang K, Clemens MG, De Maio A: Posttranscriptional regulation of connexin 32 expression in liver during acute inflammation. J Cell Physiol 1996;166:461–467.
53.
Jara PI, Boric MP, Saez JC: Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischemia-reperfusion. Proc Natl Acad Sci USA 1995;92:7011–7015.
54.
Gingalewski C, De Maio A: Differential decrease in connexin 32 expression in ischemic and nonischemic regions of rat liver during ischemia/reperfusion. J Cell Physiol 1997;171:20–27.
55.
Temme A, Ott T, Haberberger T, Traub O, Willecke K: Acute-phase response and circadian expression of connexin26 are not altered in connexin32-deficient mouse liver. Cell Tissue Res 2000;300:111–117.
56.
Green CR, Severs NJ: Robert Feulgen Prize Lecture. Distribution and role of gap junctions in normal myocardium and human ischaemic heart disease. Histochemistry 1993;99:105–120.
57.
Fernandez-Cobo M, Gingalewski C, Drujan D, De Maio A: Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine 1999;11:216–224.
58.
Fernandez-Cobo M, Gingalewski C, De Maio A: Expression of the connexin 43 gene is increased in the kidneys and the lungs of rats injected with bacterial lipopolysaccharide. Shock 1998;10:97–102.
59.
John GR, Scemes E, Suadicani SO, Liu JS, Charles PC, Lee SC, Spray DC, Brosnan CF: IL-1beta differentially regulates calcium wave propagation between primary human fetal astrocytes via pathways involving P2 receptors and gap junction channels. Proc Natl Acad Sci USA 1999;96:11613–11618.
60.
Tonon R, D’Andrea P: The functional expression of connexin 43 in articular chondrocytes is increased by interleukin 1beta: Evidence for a Ca2+-dependent mechanism. Biorheology 2002;39:153–160.
61.
Branes MC, Contreras JE, Saez JC: Activation of human polymorphonuclear cells induces formation of functional gap junctions and expression of connexins. Med Sci Monit 2002;8:BR313–BR323.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.